Cambodia vs Morocco: HIV/AIDS deaths averted by antiretroviral therapy
Cambodia
1,355 deaths
in 2024
Morocco
1,213 deaths
in 2024
Cambodia rank
68th
Morocco rank
70th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cambodia
- Morocco
How they compare
Cambodia currently reports 1,355 deaths against 1,213 deaths in Morocco, a difference of 142 deaths.
That makes Cambodia's figure about 1.1 times Morocco's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Morocco ahead.
Cambodia ranks 68th and Morocco ranks 70th of 157 countries.
Cambodia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cambodia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,701 deaths | 183.06 deaths | 1,518 deaths | Cambodia |
| 2010s | 3,140 deaths | 725.97 deaths | 2,414 deaths | Cambodia |
| 2020s | 1,580 deaths | 1,101 deaths | 479.21 deaths | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cambodia or Morocco?
- Cambodia, at 1,355 deaths against 1,213 deaths in Morocco as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cambodia and Morocco?
- 142 deaths, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Morocco?
- 35 years are reported by both, from 1990 to 2024.
- How do Cambodia and Morocco rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cambodia ranks 68th and Morocco ranks 70th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.